| 2006 |
Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. |
Molecular cancer |
192 |
16709241 |
| 2010 |
Effects of 5-FU. |
Advances in experimental medicine and biology |
113 |
20738018 |
| 2019 |
FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression. |
Scientific reports |
110 |
30728402 |
| 2018 |
Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells. |
Experimental & molecular medicine |
99 |
30111797 |
| 2007 |
Drug resistance to 5-FU linked to reactive oxygen species modulator 1. |
Biochemical and biophysical research communications |
99 |
17537404 |
| 1998 |
The role of dihydropyrimidine dehydrogenase (DPD) modulation in 5-FU pharmacology. |
Oncology (Williston Park, N.Y.) |
92 |
9830621 |
| 2019 |
LncRNA NEAT1 knockdown attenuates autophagy to elevate 5-FU sensitivity in colorectal cancer via targeting miR-34a. |
Cancer medicine |
86 |
31802650 |
| 2022 |
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis. |
Cell reports |
85 |
35977477 |
| 2022 |
Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis. |
International journal of molecular sciences |
84 |
35408903 |
| 2024 |
tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB. |
Journal of experimental & clinical cancer research : CR |
70 |
39153969 |
| 2016 |
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53. |
Oncotarget |
70 |
27385096 |
| 2020 |
LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness. |
Cell death & disease |
64 |
33168814 |
| 2021 |
Theabrownin from Fu Brick Tea Exhibits the Thermogenic Function of Adipocytes in High-Fat-Diet-Induced Obesity. |
Journal of agricultural and food chemistry |
60 |
34581185 |
| 2009 |
MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer. |
Annals of oncology : official journal of the European Society for Medical Oncology |
60 |
19465420 |
| 2011 |
Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression. |
Biochemical and biophysical research communications |
58 |
21806965 |
| 1996 |
The fu gene discriminates between pathways to control dpp expression in Drosophila imaginal discs. |
Mechanisms of development |
57 |
8861096 |
| 2015 |
Quercetin induces apoptosis and enhances 5-FU therapeutic efficacy in hepatocellular carcinoma. |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine |
56 |
26628295 |
| 2017 |
Mutation of serine/threonine protein kinase 36 (STK36) causes primary ciliary dyskinesia with a central pair defect. |
Human mutation |
55 |
28543983 |
| 2022 |
Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer. |
Medical oncology (Northwood, London, England) |
49 |
36308643 |
| 2004 |
Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres. |
International journal of pharmaceutics |
42 |
15113618 |
| 2020 |
nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients. |
Cancer medicine |
41 |
33099898 |
| 2022 |
Resveratrol alleviated 5-FU-induced cardiotoxicity by attenuating GPX4 dependent ferroptosis. |
The Journal of nutritional biochemistry |
38 |
36442718 |
| 2019 |
MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27. |
Cellular & molecular biology letters |
38 |
30915129 |
| 2013 |
Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer. |
Pathology oncology research : POR |
36 |
24122668 |
| 2024 |
An RNA damage response network mediates the lethality of 5-FU in colorectal cancer. |
Cell reports. Medicine |
34 |
39378883 |
| 2022 |
SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer. |
Cell death discovery |
34 |
35422067 |
| 2019 |
Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation. |
Scientific reports |
34 |
31729451 |
| 2016 |
CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer. |
OncoTargets and therapy |
34 |
27942222 |
| 2006 |
Regulation of Ci and Su(fu) nuclear import in Drosophila. |
Developmental biology |
34 |
16595130 |
| 2023 |
Wei-fu-chun tablet halted gastric intestinal metaplasia and dysplasia associated with inflammation by regulating the NF-κB pathway. |
Journal of ethnopharmacology |
32 |
37567428 |
| 2022 |
METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma. |
International journal of oncology |
32 |
35856434 |
| 2021 |
CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis. |
Cancer cell international |
31 |
34281530 |
| 2017 |
MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer. |
Biochemical and biophysical research communications |
31 |
28235486 |
| 2015 |
Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. |
Oncotarget |
31 |
25909168 |
| 2021 |
DCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance. |
Frontiers in cell and developmental biology |
29 |
34095137 |
| 2015 |
AMPK activator AICAR promotes 5-FU-induced apoptosis in gastric cancer cells. |
Molecular and cellular biochemistry |
29 |
26497305 |
| 2013 |
Fused (Stk36) is a ciliary protein required for central pair assembly and motile cilia orientation in the mammalian oviduct. |
Developmental dynamics : an official publication of the American Association of Anatomists |
29 |
23907739 |
| 2003 |
Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas. |
Anticancer research |
29 |
12926096 |
| 2023 |
Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment. |
International journal of molecular sciences |
28 |
36902421 |
| 2021 |
LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan. |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
28 |
34474344 |
| 2020 |
Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. |
JCI insight |
28 |
32213714 |
| 2020 |
5-FU inhibits migration and invasion of CRC cells through PI3K/AKT pathway regulated by MARCH1. |
Cell biology international |
28 |
33085122 |
| 2019 |
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers. |
The Journal of pathology |
28 |
31518438 |
| 2014 |
Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells. |
Anti-cancer drugs |
28 |
24366282 |
| 2024 |
c-Fos regulated by TMPO/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer. |
Cell death & disease |
27 |
38233377 |
| 2020 |
Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer. |
Cancer management and research |
27 |
33177877 |
| 2019 |
Inhibition of protein FAK enhances 5-FU chemosensitivity to gastric carcinoma via p53 signaling pathways. |
Computational and structural biotechnology journal |
25 |
31969973 |
| 2022 |
Mesenchymal stem cell‑derived exosomes loaded with 5‑Fu against cholangiocarcinoma in vitro. |
Molecular medicine reports |
24 |
35543159 |
| 2021 |
Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer. |
Oncogene |
24 |
34845374 |
| 2022 |
Paraprobiotics and Postbiotics of Lactobacillus delbrueckii CIDCA 133 Mitigate 5-FU-Induced Intestinal Inflammation. |
Microorganisms |
23 |
35889136 |
| 2020 |
Lactobacillus-derived metabolites enhance the antitumor activity of 5-FU and inhibit metastatic behavior in 5-FU-resistant colorectal cancer cells by regulating claudin-1 expression. |
Journal of microbiology (Seoul, Korea) |
23 |
33125671 |
| 2016 |
B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu. |
Oncology reports |
23 |
27175567 |
| 2019 |
MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells. |
European review for medical and pharmacological sciences |
22 |
31115003 |
| 2014 |
Expression of ABCB6 is related to resistance to 5-FU, SN-38 and vincristine. |
Anticancer research |
22 |
25202056 |
| 2014 |
The E3 ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of Fu. |
The Journal of biological chemistry |
22 |
25278022 |
| 2016 |
DKK4 enhances resistance to chemotherapeutics 5-Fu and YN968D1 in colorectal cancer cells. |
Oncology letters |
20 |
28356933 |
| 2024 |
ALKBH4 impedes 5-FU Sensitivity through suppressing GSDME induced pyroptosis in gastric cancer. |
Cell death & disease |
19 |
38902235 |
| 2023 |
KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer. |
Cancer biology & therapy |
19 |
37431852 |
| 2024 |
Chinese medicinal formula Fu Xin decoction against chronic heart failure by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway. |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
18 |
38599064 |
| 2021 |
Nuclear Translocation of SRPKs Is Associated with 5-FU and Cisplatin Sensitivity in HeLa and T24 Cells. |
Cells |
18 |
33808326 |
| 2021 |
CMPK1 Regulated by miR-130b Attenuates Response to 5-FU Treatment in Gastric Cancer. |
Frontiers in oncology |
18 |
33816278 |
| 2021 |
Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma. |
Cancer chemotherapy and pharmacology |
18 |
34132895 |
| 2025 |
FOXC1-mediated serine metabolism reprogramming enhances colorectal cancer growth and 5-FU resistance under serine restriction. |
Cell communication and signaling : CCS |
17 |
39773485 |
| 2024 |
Super-enhancer Activates Master Transcription Factor NR3C1 Expression and Promotes 5-FU Resistance in Gastric Cancer. |
Advanced science (Weinheim, Baden-Wurttemberg, Germany) |
17 |
39731339 |
| 2022 |
LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer. |
Carcinogenesis |
17 |
35914269 |
| 2013 |
The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression. |
Digestive diseases and sciences |
17 |
23314856 |
| 2011 |
A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment. |
Journal of translational medicine |
17 |
21619678 |
| 2007 |
A possible role of mouse Fused (STK36) in Hedgehog signaling and Gli transcription factor regulation. |
Journal of cell communication and signaling |
17 |
18600476 |
| 1981 |
The target cell determinants of the antitumor actions of 5-FU: does FU incorporation into RNA play a role? |
Cancer treatment reports |
17 |
6179616 |
| 2025 |
Low miR-224-5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4. |
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy |
16 |
39956015 |
| 2022 |
Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors. |
Communications biology |
16 |
36316440 |
| 2021 |
HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU. |
Bioscience reports |
16 |
33860796 |
| 2021 |
Knockdown of circNRIP1 sensitizes colorectal cancer to 5‑FU via sponging miR‑532‑3p. |
Oncology reports |
16 |
34396434 |
| 2020 |
Cannabidiol on 5-FU-induced oral mucositis in mice. |
Oral diseases |
16 |
32400905 |
| 2020 |
miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating β-catenin pathway. |
Biochemical and biophysical research communications |
16 |
32977944 |
| 2020 |
Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer. |
Cancer cell international |
16 |
33292253 |
| 2019 |
Imatinib inhibits the regrowth of human colon cancer cells after treatment with 5-FU and cooperates with vitamin D analogue PRI-2191 in the downregulation of expression of stemness-related genes in 5-FU refractory cells. |
The Journal of steroid biochemistry and molecular biology |
16 |
30772447 |
| 2022 |
Effects of Fu's subcutaneous needling on mitochondrial structure and function in rats with sciatica. |
Molecular pain |
15 |
35670088 |
| 2020 |
Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer. |
Journal of Cancer |
15 |
32742490 |
| 2016 |
Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma. |
American journal of cancer research |
15 |
27648358 |
| 2009 |
Enhanced cytotoxicity of 5-FU by bFGF through up-regulation of uridine phosphorylase 1. |
Molecules and cells |
15 |
19714313 |
| 2024 |
5-FU promotes HBV replication through oxidative stress-induced autophagy dysfunction. |
Free radical biology & medicine |
14 |
38215891 |
| 2021 |
Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur). |
Acta clinica Belgica |
14 |
33423619 |
| 2021 |
Long noncoding RNA CRART16 confers 5-FU resistance in colorectal cancer cells by sponging miR-193b-5p. |
Cancer cell international |
14 |
34844630 |
| 2020 |
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer. |
Aging |
14 |
31896739 |
| 2019 |
MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma. |
European review for medical and pharmacological sciences |
14 |
31799650 |
| 2017 |
NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations. |
Oncotarget |
14 |
28915668 |
| 2025 |
KLF6-mediated recruitment of the p300 complex enhances H3K23su and cooperatively upregulates SEMA3C with FOSL2 to drive 5-FU resistance in colon cancer cells. |
Experimental & molecular medicine |
13 |
40082673 |
| 2025 |
Pectolinarigenin mitigates 5-FU-induced intestinal mucositis via suppressing ferroptosis through activating PPARγ/GPX4 signaling. |
Phytomedicine : international journal of phytotherapy and phytopharmacology |
13 |
40414047 |
| 2025 |
Targeting the JAK2-STAT3-UCHL3-ENO1 axis suppresses glycolysis and enhances the sensitivity to 5-FU chemotherapy in TP53-mutant colorectal cancer. |
Acta pharmaceutica Sinica. B |
13 |
40487654 |
| 2022 |
Genome-wide CRISPR Screening Reveals Pyrimidine Metabolic Reprogramming in 5-FU Chronochemotherapy of Colorectal Cancer. |
Frontiers in oncology |
13 |
35903686 |
| 2022 |
Synthesis and Chemopreventive Potential of 5-FU/Genistein Hybrids on Colorectal Cancer Cells. |
Pharmaceuticals (Basel, Switzerland) |
13 |
36297411 |
| 2012 |
TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells. |
Anatomical record (Hoboken, N.J. : 2007) |
13 |
23125179 |
| 2004 |
The FU gene and its possible protein isoforms. |
BMC genomics |
13 |
15268766 |
| 1998 |
Irinotecan plus 5-FU and leucovorin in advanced colorectal cancer: North American trials. |
Oncology (Williston Park, N.Y.) |
13 |
9726093 |
| 2019 |
H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA. |
Biochemical and biophysical research communications |
12 |
31582208 |
| 2023 |
Hungatella hathewayi impairs the sensitivity of colorectal cancer cells to 5-FU through decreasing CDX2 expression. |
Human cell |
11 |
37477870 |
| 2023 |
Vactosertib potently improves anti-tumor properties of 5-FU for colon cancer. |
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences |
11 |
37740873 |
| 2022 |
Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics. |
Molecular therapy : the journal of the American Society of Gene Therapy |
11 |
35933584 |
| 2019 |
BET inhibitor bromosporine enhances 5-FU effect in colorectal cancer cells. |
Biochemical and biophysical research communications |
11 |
31708100 |